<DOC>
	<DOCNO>NCT00670319</DOCNO>
	<brief_summary>To study effect long-term treatment raloxifene , compare placebo , rate new vertebral fracture osteoporotic postmenopausal woman without exist vertebral fracture .</brief_summary>
	<brief_title>Comparison Raloxifene Hydrochloride Placebo Treatment Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Ambulatory postmenopausal woman free severe chronically disable condition , life expectancy least 5 year , expect remain ambulatory throughout entire study , expect return followup visit . Women last menstrual period least 2 year begin study . Women language barrier , cooperative , give informed consent enter study Substudy 1 : Femoral neck lumbar spine BMD measurements 2.5 standard deviation normal peak bone mass healthy , premenopausal woman ( Tscore great equal 2.5 ) . Substudy 2 : Either least one moderate least two mild vertebral fracture presence low BMD ( specify ) least two moderate vertebral fracture , regardless BMD . Patients know current bone disorder primary osteoporosis , hyperparathyroidism , Paget 's disease , renal osteodystrophy , osteomalacia Patients experience clinically severe postmenopausal symptom begin study require estrogenreplacement therapy Patients know , suspect , history carcinoma breast estrogendependent neoplasia Patients history cancer within previous 5 year Patients abnormal uterine bleeding Patients history deep venous thrombosis , thromboembolic disorder , cerebral vascular accident within past 10 year except patient history deep venous thrombosis due accident Patients endocrine disorder require pharmacologic therapy except type II diabetes Patients biochemically euthyroid change thyroid replacement therapy 2 month start study . Patients acute chronic liver disease Patients impair kidney function Patients active renal lithiasis Patients know , severe untreated malabsorption syndromes Patients pathologic fracture ( substudies ) patient Substudy II whose vertebral fracture clearly result automobile accident severely traumatic accident Patients satisfactory baseline thoracic lumbar xray view obtain Patients less two lumbar le four thoracic vertebra unfractured evaluable incident fracture Treatment therapeutic dos follow medication recently 6 month begin study : Androgen , Calcitonin , Estrogen , Progestin Treatment therapeutic dos systemic corticosteroid 1 month 12 month begin study . Patients receive therapeutic dos fluorides Patients received bisphosphonate therapy 14 day past 18 month receive bisphosphonate therapy within last 6 month begin study . Patients require highdose heparinization ( &gt; 7500 U/day ) study entry total period time presumably exceed 6 month Patients treat 50,000 IU vitamin D weekly recently 3 month begin study exclude . Current systemic treatment follow medication begin study : Lithium , Anticonvulsants , regular use phosphatebinding antacid .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>